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Gene expressionCaliciviruses are non-enveloped, icosahedral viruses with a single-stranded, positive sense RNA genome.
Transposon-mediated insertional mutagenesis was used to insert a transprimer sequence into random sites
of an infectious full-length cDNA clone of the feline calicivirus (FCV) genome. A site in the LC gene (encoding
the capsid leader protein) of the FCV genome was identiﬁed that could tolerate foreign insertions, and two
viable recombinant FCV variants expressing LC fused either to AcGFP, or DsRedFP were recovered. The effects
of the insertions on LC processing, RNA replication, and stability of the viral genome were analyzed, and the
progression of a calicivirus single infection and co-infection were captured by real-time imaging ﬂuorescent
microscopy. The ability to engineer viable recombinant caliciviruses expressing foreign markers enables new
approaches to investigate virus and host cell interactions, as well as studies of viral recombination, one of the
driving forces of calicivirus evolution.it, National Institute of Allergy
0 South Drive, Bldg. 50, Room
.
Inc.Published by Elsevier Inc.Introduction
Feline calicivirus (FCV), a member of the genus Vesivirus of the
family Caliciviridae, is an important disease agent in cats. Clinical signs
of disease can vary among FCV strains, and include conjunctivitis, oral
ulceration, upper respiratory disease, and in severe cases, a systemic
infection (Gaskell, 1985; Pesavento et al., 2008; Radford et al., 2007).
Although vaccines for FCV have been employed for over 20 years, a
high incidence of mortality can occur in isolated outbreaks (Hurley et
al., 2004; Ossiboff et al., 2007). Vaccine failure has been attributed to
the absence of sterilizing immunity, occasional vaccine breakdowns,
and in the case of the live vaccine, occasional vaccine-induced disease
(Radford et al., 2006).
Feline caliciviruses contain an approximately 7.8-kb positive-
sense RNA genome that is covalently linked at the 5′-end to the viral
protein VPg (Herbert et al., 1997; Mitra et al., 2004; Schaffer et al.,
1980), and polyadenylated at the 3′-end (Neill and Mengeling, 1988).
The viral genome is packaged (Burroughs and Brown, 1978) into small
(approximately 35 nm in diameter), nonenveloped, icosahedral
particles (T=3) that are composed of 180 copies of VP1 and
approximately 1-10 copies of VP2 (Chen et al., 2006, 2003; Peterson
and Studdert, 1970; Prasad et al., 1994, 1999; Sosnovtsev and Green,2000). The genome consists of three open reading frames. Open
reading frame 1 (ORF1) encodes a large polyprotein precursor that is
proteolytically cleaved by a viral protease into six mature nonstruc-
tural proteins (NS1-NS6/7) (Sosnovtsev et al., 1999, 2002). ORF2
encodes a precursor to the major capsid protein that is post-
translationally cleaved into the leader capsid protein (LC; of unknown
function) and the mature capsid protein (VP1) (Carter et al., 1992;
Fretz and Schaffer, 1978; Neill et al., 1991; Sosnovtsev et al., 1998).
ORF3 encodes a small, basic protein (VP2) that is reported as essential
for virus infectivity and capsid stability (Bertolotti-Ciarlet et al., 2003;
Glass et al., 2000; Sosnovtsev et al., 2005; Sosnovtsev and Green,
2000).
In addition to the genus Vesivirus, the family Caliciviridae contains
three other established genera: Norovirus, Sapovirus, and Lagovirus
(Green, 2001; Green et al., 2000). Evidence for further diversity within
the family has been reported (Farkas et al., 2008; Oliver et al., 2004,
2006). Human noroviruses, which are the major cause of non-
bacterial gastroenteritis in humans, are of particular importance for
public health (Green et al., 2002a; Kapikian, 2000; Kapikian et al.,
1972). Pediatric gastroenteritis caused by noroviruses is now
recognized as second only to that caused by the rotaviruses (Patel
et al., 2008, 2009; Trujillo et al., 2006). Despite advances in the
development of molecular tools for the study of these viruses such as a
human norovirus replicon system (Chang and George, 2007; Chang
et al., 2006) and a cultivatable murine norovirus (MNV) (Karst et al.,
2003; Wobus et al., 2004), analysis of the replication strategy of the
human viruses has been challenging due to the unavailability of a
permissive cell culture system.
Table 1
Two sites within the ORF2 and 3 region of FCV can tolerate a 15-nt insertion.
Viral
Protein
Open
reading
frame
(ORF)
Protein
locationa: nts
(genome), aa
(ORF)
Site of
insertiona: nts
(genome), aa
(ORF)
Nucleotide sequence of
15-nt insertionb
LC ORF2 5314-7320
1-124
5577/5578
88/89
CACTGGtgtttaaacaactggAATGAG
VP2 ORF3 7317-7637
1-107
7322/7323
2/3
ATGAATtgtttaaacatgaatTCGATC
a Nucleotide numbering system is based on the full-length genome of the URB strain
(GenBank Accession No. L40021).
b Nucleotides in upper case letters correspond to the FCV genome, and nucleotides in
lower case letters correspond to the 15-nt insertion.
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Green, 1995), andmore recently forMNV(Chaudhry et al., 2007;Ward
et al., 2007) have facilitated studies of the calicivirus replication
strategy (Chaudhry et al., 2007; Mitra et al., 2004; Sosnovtsev et al.,
1998, 2005;Ward et al., 2007). Although antigenic domain swaps have
been engineered successfully into recombinant FCV strains with
reverse genetics (Neill et al., 2000), there are no reports of the recovery
of viable caliciviruses expressing foreign proteins. One strategy to
engineer recombinant viruses derived from cDNA clones employs a
modiﬁed Tn7 transposon mutagenesis system (Atasheva et al., 2007;
Moradpouret al., 2004). Thismutagenesis systeminserts a15-basepair
sequence into infectious cDNAmolecules at random sites (Biery et al.,
2000; Craig, 1996; Peters andCraig, 2001; StellwagenandCraig, 1997a,
1997b), and viruses that can tolerate insertions are recovered and
characterized. The Tn7 transposon system has been successfully
applied to single-stranded RNA viruses to identify sites within the
viral genome that can tolerate and stably express foreign proteins
(Atasheva et al., 2007; Moradpour et al., 2004; Teterina et al., 2009).
The goal of this study was to determine whether transposon
mutagenesis could be applied to the generation of recombinant
caliciviruses expressing foreign sequences. A region of the FCV
genome that included the entire ORF2 and the 5′ end of ORF3 was
scanned to identify sites that could tolerate the 15-nt insertion. Two
sites were identiﬁed: one mapped within the LC protein (ORF2), and
the other to the extreme N-terminus of VP2 (ORF3). Further analysis
revealed that the FCV genome could tolerate larger sequence
insertions only in the LC site, a viral protein of unknown function.
Two recombinant FCV viruses were engineered to express either the
reef coral Discosoma sp. red (DsRed) or the jellyﬁsh Aequorea
coerulescens green (GFP) ﬂuorescent proteins fused to the LC protein.
The progression of viral CPE and protein expression were captured by
real-time imaging, followed by generation of the ﬁrst direct evidence
for co-infection of a single cell by two distinct calicivirus variants. The
ability to engineer viable, recombinant calicivirus variants expressing
foreign markers should enhance many areas of research, including
elucidation of the basic mechanisms of replication and evolution.
Results
Identiﬁcation of Sites in the FCV Subgenomic Region that can Tolerate
an Insertion
In our initial experiments to identify sites in the FCV genome that
can tolerate insertions, a transposon mutagenesis approach was used
to insert a 15-bp sequence (with a unique PmeI restriction enzyme
site) at random locations throughout the entire ORF2 and the ﬁrst 12
nucleotides of ORF3. The mutagenized FCV region was then cloned
back into the infectious full-length cDNA clone, pR6, replacing wt
sequences with the mutagenized sequences. In general, the titer of
virus recovered from the library of mutagenized plasmids was 10
plaque forming units (p.f.u.), approximately 2 log10 lower than the
titer of virus recovered from a full-length clone encoding wild-type
(wt) virus. There was a high incidence of recovered wt virus after
transfection with the mutagenized pool, which was likely due to
instability of the recombinant viruses and reversion to wt. From the
initial screening of recovered viruses, 3 out of 23 analyzed plaques
were identiﬁed by sequence analysis as recombinant viruses contain-
ing a 15-nt insertion (Table 1), although 2 of the 3 plaques were
identical recombinants. The LC protein tolerated the 15-nt insertion at
the C-terminus (this recombinant was recovered twice from the
library; the site of insertion is bordered by nucleotides 5577 and
5578), and VP2 tolerated the insertion at its N-terminus (bordered by
nucleotides 7322 and 7323). Reverse genetics was employed to insert
small epitope tags into these sites (HA, FLAG, and a tetra cysteine
motif). Virus was recovered from recombinant cDNA clones expres-
sing each of the three epitope tags fused to the LC, and the presence ofeach sequence in the viral genome was conﬁrmed by sequence
analysis. Of the three epitope tags that were inserted into the VP2
coding sequence, virus was recovered only from the recombinant
cDNA clone that contained the HA insertion.
The ability of the LC protein to tolerate the insertion of foreign
sequences was of interest because the function of this protein, which
is unique to the genus Vesivirus, has not yet been identiﬁed. The LC
protein is translated as part of the 72 kDa capsid precursor (668 amino
acids in length) encoded in ORF2. The viral cysteine proteinase cleaves
the precursor immediately following amino acid 124, releasing the LC
(amino acids 1-124) and the mature VP1 (amino acids 125-668). To
facilitate cloning of markers into the LC in order to study its function
and to evaluate the characteristics of representative recombinant
viruses, the pR6 infectious clone was engineered at the LC insertion
site to create four new unique restriction sites (PmeI, KpnI, BspEI,
AﬂII), bordered by nucleotides 5577 and 5578 of the FCV genome,
(designated as pR6-LC; Fig. 1A). Viable viruses were recovered from
the pR6-LC clone (data not shown).
Viability of Recombinant FCV Variants
In order to monitor a FCV infection in real-time, the coding
sequence of the monomeric versions of GFP and DsRed were
engineered into the pR6-LC clone using the unique KpnI and AﬂII
sites (Fig. 1A), with the addition of a three amino acid “linker”
sequence (GGS) ﬂanking the ﬂuorescent protein. The recombinant
clones were designated pR6-LC-GFP and pR6-LC-DsRed, for the GFP
and DsRed harboring constructs, respectively (Fig. 1B).
The recombinant clones yielded viable recombinant viruses that
formed plaques in CRFK cell monolayers (Fig. 2A, panels 1-4). There
was no visible difference in the CPE caused by the recombinant viruses
and vR6 (cell rounding; Fig. 2A, panels 9-12). Microscopy revealed
that plaques formed by vR6-LC-GFP and vR6-LC-DsRed were
ﬂuorescent at the expected wavelengths, and no ﬂuorescence was
observed in vR6-infected cells (Fig. 2A, panels 5-8).
The growth kinetics of the recombinant FCV viruses were
compared with that of the wild-type parental virus, vR6, in a
multi-step growth curve (Fig. 2B). Cell monolayers were infected
with viruses at an MOI of 0.01 and samples were collected at 0, 6, 12,
18, 24, 30, and 48 hours p.i. The growth curves for all viruses were
similar through the ﬁrst 18 hours. At 24 hours p.i., vR6 reached a
peak titer of approximately one log10 higher than the recombinant
viruses. By 48 hours p.i., viral titers were similar for all three viruses.
These data indicate that the recombinant viruses spread similarly to
wild-type, however they have a maximum titer one log10 lower than
wild-type.
Characterization of LC-fusion Precursor Protein In Vitro and in
Virus-infected Cells
The recovery of viruses expressing relatively large ﬂuorescent
proteins fused to the LC prompted us to examine the cleavage
Fig. 1. Recombinant FCV constructs. (A) Schematic diagram showing the recombinant FCV that was engineered to have a multiple cloning site encoded within the LC. The location of
the multiple cloning site in the LC is indicated by an arrow. E/A corresponds to the cleavage site of the ORF2 precursor. Nucleotide numbers correspond to the Urbana strain of FCV
(Genbank accession no. L40021). (B) Recombinant FCV constructs. cDNA infectious clone constructs showing the site of insertion of GFP (pR6-LC-GFP) and DsRed (pR6-LC-DsRed).
(C) pCI expression vectors containing the subgenomic region of pR6, pR6-LC-GFP or pR6-LC-DsRed. rLC, recombinant LC.
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possible that the reduction in virus yield was due to a lower efﬁciency
of the precursor cleavage event. The subgenomic regions of vR6, vR6-
LC-GFP and vR6-LC-DsRed were each cloned into the pCI expression
vector and the resulting plasmids, designated pCI-vR6, pCI-LC-GFP,
pCI-LC-DsRed, contained the ﬁrst AUG of ORF2 under the control of a
T7 promoter. The radiolabeled translation products generated in a
coupled in vitro transcription and translation reaction were resolved
by SDS-PAGE, and the expected bands corresponding to proteins with
predicted molecular masses of 73 (vR6), 101 (vR6-LC-GFP), and 100
(vR6-LC-DsRed) kDa were observed (Fig. 3A). Additional minor bands
corresponding to proteins of lower molecular weight were likely the
result of efﬁcient internal translation at downstream AUGs of ORF2, as
noted previously (Sosnovtsev et al., 1998). To test for authentic
cleavage of the recombinant precursor, radiolabeled TNT products
derived from the pCI vectors were incubated at 37 °C for 3 hr with a
lysate (nonradiolabeled) prepared from either vR6-infected, or mock-
infected, CRFK cells (Fig. 3B). The products of this incubation were
immunoprecipitated using speciﬁc antibodies raised against the LC
and the complexes were analyzed by SDS-PAGE and visualized with
autoradiography. The expected cleavage event occurred only when
the TNT samples were incubated with vR6-infected CRFK lysates,
which are known to contain the active viral proteinase (lanes 4-6)(Sosnovtsev et al., 1998). The cleaved LC protein in both the wt and
recombinant form (indicated with an asterisk) were observed in
addition to the approximately 60 kDa mature capsid (indicated with
an arrow) that co-precipitated, as observed previously (Sosnovtsev
and Green, 2000). Furthermore, anti-FCV virion serum was used to
monitor VP1 processing over time in FCV-infected cells. The
production of mature VP1 was similar for the three viruses (Fig. 3C),
suggesting that processing of the capsid precursor by the viral
proteinase (Sosnovtsev et al., 1998) was unaffected. Taken together,
these data show that the insertion of the ﬂuorescent protein into the
LC does not affect the observed efﬁciency of the capsid precursor
cleavage both in vitro and in infected cells.
Western blot analyses of CRFK cells infected with vR6, vR6-LC-GFP,
and vR6-LC-DsRed were performed to investigate whether the
recombinant FCV variants expressed LC as an intact fusion protein
(Fig. 3D). The anti-LC serum detected the expected LC protein of
14 kDa in wt infected cells (lane 1), and larger LC fusion proteins in
cells infected with vR6-LC-GFP (lane 2) and vR6-LC-DsRed (lane 3). A
band of the expected molecular mass of approximately 42 kDa for the
recombinant LC fusion protein was also detected using antibodies
speciﬁc for GFP (lane 6) or DsRed (lane 11). It should be noted that
when detecting recombinant LC proteins, bands corresponding to
proteins of lower molecular masses were observed in some Western
Fig. 2. Recombinant FCV expressing GFP and DsRed fused to the LC are viable and show growth kinetics similar to wt FCV. (A) Virus serial dilutions were added to CRFKmonolayers of
a 6-well plate and incubated for 60 min, at which point an agarose overlay was added. Approximately 48 h later, ﬂuorescent and phase images were captured of vR6 (panels 5–6, 9–
10), vR6-LC-GFP (panels 7, 11) and vR6-LC-DsRed (panels 8, 12) plaques using a Leica DMI4000 B microscope. Fluorescent images correspond to signals detected when using ﬁlters
speciﬁc to GFP and DsRed (panels 5–8). The agarose overlay was removed, and the cells were stained with crystal violet and images were taken of plaques (panels 1–4). (B) CRFK
monolayers were infected at a multiplicity of infection (MOI) of 0.01 and virus titer was determined by plaque assay. The mean log10 titer is shown with a standard deviation of 1.
Time-points were taken in duplicate, and each time-point duplicate was plaqued in duplicate. T=0 represents the virus titer of washed monolayers after a 1-h incubation period to
allow for virus adsorption.
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the subgenomic RNA transcript, nonspeciﬁc degradation of the LC
protein, or reversion of the population bearing recombinant LC to wt
LC (see Fig. 6).
Northern Blot Analysis of Recombinant Viral RNA
Two abundant positive sense RNA species corresponding to an
approximately 7.8kbgenomic and2.5 kb subgenomicRNAareproducedduring an FCV infection (Carter, 1990; Green et al., 2002b; Herbert et al.,
1997; Neill and Mengeling, 1988). In order to determine whether
expression of these RNA species were affected by the introduction of
foreign RNA into the subgenomic region, a Northern blot analysis was
performed to determine the characteristics of the replicating RNA of
cells infected with vR6-LC-GFP and vR6-LC-DsRed (Fig. 4).
RNA was isolated 8 hours p.i. from CRFK cells infected with vR6,
vR6-LC-GFP or vR6-LC-DsRed. A biotinylated probe speciﬁc for the
FCV ORF2 detected RNA consistent with the expected size of the wt
22 E.J. Abente et al. / Virology 400 (2010) 18–31subgenomic (approximately 2.5 kb) and genomic (approximately
7.7 kb) RNA for vR6 (Fig. 4, lane 1), along with additional minor virus-
speciﬁc RNA species noted in previous studies (Carter, 1990). In
contrast, RNA isolated from recombinant FCV infected cells yieldedtwo larger abundant RNA species, with an expected shift in the size of
subgenomic (approximately 3.2 kb) and genomic (approximately
8.4 kb) RNAs for the vR6-LC-GFP (Fig. 4, lane 2) and vR6-LC-DsRed
viruses (Fig. 4, lane 3). A longer exposure of the vR6-LC-DsRed RNA
Fig. 4. Northern blot analysis of genomic and subgenomic RNA from recombinant FCV-
infected cells. CRFK monolayers of a 6-well plate were infected with vR6, vR6-LC-GFP
and vR6-LC-DsRed at an MOI of 1, and approximately 8 h later total RNA was extracted
using Trizol reagent (Invitrogen). The RNA was analyzed on a 1% agarose gel that was
dried and treated with a biotinylated RNA sense probe that was then exposed to ﬁlm. G,
genomic RNA; SG, subgenomic RNA.
23E.J. Abente et al. / Virology 400 (2010) 18–31Northern blot is included in lane 5 to show the presence of the
genomic RNA. These data demonstrate that the ﬂuorescent protein
coding sequence is present andmaintained in the genome throughout
multiple replication cycles. It also demonstrates that the subgenomic
RNA is transcribed at levels similar to wt, indicating that the
subgenomic promoter was functional in the presence of a large
proximal insertion.
Real-time Visualization of LC Production During a Single and
Co-infection
Infection studies were performed with the individual recombinant
viruses tomonitor an FCV infection in real-time (Fig. 5, Supplementary
Video 1, 2). A representative video (Supplementary Video 2) captured
approximately 20 cells expressing DsRed in a CRFK monolayer
infected with vR6-LC-PmeIDsRed at a high MOI (5). As the
progression of CPE advances and apoptotic changes become
apparent, an increase in the intensity of expression of DsRed can
be observed. The initial localization of the LC was identiﬁed as
perinuclear, as seen in Supplementary Video 2, and future studies
will examine co-localization with cellular markers.Fig. 3. Evidence for efﬁcient cleavage of the LC precursor of pR6-LC-GFP and pR6-LC-DsRed co
DsRed were cloned into the pCI expression vector. The cloned pCI expression vectors were
methionine. The samples were subjected to SDS-PAGE in a 4–12% Tris-glycine gel (Lonza). Th
TNT samples were treated with either unlabeled mock (lanes 1–3) or vR6-infected (lan
hyperimmune anti-LC sera, and subsequently subjected to SDS-PAGE in a 4-12% Tris-glycin
exposed to ﬁlm. (C) CRFK monolayers of a 6-well plate were infected with vR6, vR6-LC-GFP
6 h p.i. Lysates were loaded on a 4–20% Tris-glycine gel and subjected to SDS-PAGE. The ge
serum to detect mature VP1 production. (D) Resuspended pellets from CRFK cells infected w
SDS-PAGE (4–20% Tris-glycine gel), and subsequently transferred to a nitrocellulose memb
raised against bacterially expressed LC), GFP (afﬁnity puriﬁedmouse monoclonal; Clontech)
were stripped (Thermo Scientiﬁc) and the membrane reacted with anti-β-actin to serve
standards in kilodaltons (kDa) are indicated on the left and were calculated using SeeBlueThe availability of two recombinant viruses expressing distinct
reporter proteins prompted us to perform co-infection studies.
Although evidence for recombination has been documented exten-
sively in the caliciviruses, it has been difﬁcult to elucidate the
interactions of two viral genomes replicating in the same cell.
Infection of a CRFK monolayer with the GFP and DsRed recombinant
viruses yielded occasional cells expressing both red and green
markers, with co-localization evidenced by a yellow signal in the
merged images. One such single cell co-infected with both viruses
was monitored over time, and the increase in expression of GFP and
DsRed was consistent with the progression of CPE (Fig. 5). The most
intense signal from recombinant LC in a co-infection was observed
8 hours p.i. (Fig. 5; Video S1 can be viewed to observe ﬂuorescence
over a longer time course), although cells began to collapse and bleb
approximately 5-6 hours p.i., a morphology consistent with reports
of virus-induced apoptosis (Natoni et al., 2006; Roberts et al., 2003;
Sosnovtsev et al., 2003). Supplementary Video 2 (which extended
beyond the ﬁrst 9.5 hrs shown in Fig. 5) showed a continued
accumulation of recombinant LC after the cell had collapsed.
Furthermore, the LC-GFP accumulated to higher observable levels
then LC-DsRed. Several other co-infected cells were monitored as
well, but there was no clear pattern of one recombinant virus out-
competing the other.
The image analysis of co-infection enabled by the visualization of
LC trafﬁcking suggests that different viruses within the same cell can
both co-localize and maintain distinct replication sites.
Stability of Recombinant Viruses
A PCR assay was developed to track the stability of foreign inserts
in the FCV genome, similar to studies that have been performed with
recombinant polioviruses (Mueller and Wimmer, 1998) (Fig. 6A).
One clear indicator of changes in the inserted ﬂuorescent protein
gene was the appearance of non-ﬂuorescent plaques in plaque-
puriﬁed stocks. The RT-PCR diagnostics and sequencing analysis
allowed us to track the sizes and types of deletions of revertant
viruses.
RT-PCR was performed on RNA puriﬁed from ﬂuorescent and non-
ﬂuorescent plaques, and vR6 virus (Fig. 6B). The vR6 RNA yielded a
band of approximately 300 bp (Fig. 6B, lane 9). The RNA from a
ﬂuorescent plaque produced a PCR amplicon of approximately
1000 bp, the expected size of the region if bearing an intact DsRed
gene (lane 2). Five of the six nonﬂuorescent plaques from viruses
obtained immediately after recovery from an infectious cDNA clone
(lanes 3 and 4) or from pooled viruses ampliﬁed in a T-150 ﬂask (lanes
5-8) yielded a similar sized band (approximately 400 bp, lanes 3, 5-8)
that was intermediate when compared with the DsRed expressing
virus and vR6. RNA from plaque 2 (lane 4) produced a major band
matching that of vR6, and a minor band similar in size to that
produced from the other non-ﬂuorescent plaques, consistent with a
mixed population of viruses undergoing deletions and reversion to
near wild type.
PCR products from the non-ﬂuorescent plaques were gel puriﬁed
and sequenced. Plaques 1, and 3-6 contained six nucleotides from the
5′-end of the original DsRed insert, in addition to 101 nucleotidesnstructs in vitro and in vivo. (A) The subgenomic region of vR6, vR6-LC-GFP and vR6-LC-
used in a coupled in vitro transcription and translation reaction, and labeled with [35S]
e proteins were stained with GelCode Blue Stain (Pierce), dried and exposed to ﬁlm. (B)
es 4–6) lysates for 3 h. The treated samples were immunoprecipitated using rabbit
e gel (Lonza). The proteins were stained with GelCode Blue Stain (Pierce), dried and
and vR6-LC-DsRed at an MOI of 1, and lysates of a single well were collected at 2, 4, and
l was transferred to a nitrocellulose membrane and incubated with FCV-virion speciﬁc
ith the recombinant FCV variants, as well as vR6 as a positive control, were analyzed by
rane. Western blotting was performed with antibodies speciﬁc to LC (rabbit polyclonal
or DsRed (rabbit polyclonal; Clontech). After detecting the viral protein of interest, blots
as a loading control (anti-β-actin HRP conjugated antibody; Sigma). Molecular mass
Plus2 Pre-Stained Standard (Invitrogen).
Fig. 5. Real-time imaging of a co-infection.CRFK cells were co-infected with vR6-LC-GFP (MOI of 2) and vR6-LC-DsRed (MOI of 1). 2.5 h p.i. the cells were transferred to a closed
chamber (37°C/5% CO2) andmonitored over time. Images were captured every 12min for 14 h. Time (h) represents time p.i. in hours. GFP and DsRed channels correspond to signals
detected when using ﬁlters speciﬁc to GFP and DsRed. Scale bars=10 μm. For a movie derived from this experiment of LC-GFP/LC-DsRed expression during an infection, see
Supplementary Video 1.
24 E.J. Abente et al. / Virology 400 (2010) 18–31from the 3′-end of the insert separated by two small gaps (Fig. 6C).
The major band of Plaque 2 was selected for sequencing, and this
deletion variant contained 8 nucleotides of the 5′-end of the DsRed
gene insertion, and a single nucleotide that likely corresponds to the
last nucleotide of the 3′-end of the insertion (Fig. 6C).
An FCV variant that contained an HA epitope fused to the VP2
was also generated. The stability of the HA tag in ORF3 was
analyzed by sequence analysis (data not shown). Following
recovery, the VP2-HA virus was serially passaged three times, and
sequence analysis of RT-PCR products obtained from the third
passage virus showed the presence of a modiﬁed HA epitope in the
VP2 (Y—VPDYA, instead of the full YPYDVPDYA that had been
introduced). No virus was recovered from a recombinant virus
construct in which the FLAG epitope was introduced into the coding
sequence of VP2, suggesting that the particular sequence of the
insertion, in addition to length, may affect the stability and viability
of recombinant viruses.Discussion
Until now, recombinant caliciviruses generated by reverse
genetics have contained only highly-related domain swaps from
other caliciviruses (Neill et al., 2000). The trans-encapsidation of a
non-infectious FCV RNA that contains GFP fused to the VP1 sequence
has been reported, although the low efﬁciency of the trans-
encapsidation event did not allow for further characterization or
analysis of the trans-encapsidated virion (Thumfart and Meyers,
2002). The introduction of heterologous sequences into the genome
of a single-stranded positive-sense RNA virus presents several
challenges because the insertion may affect RNA secondary structure,
proteolytic processing of a polyprotein, and RNA packaging. Some
approaches that have been successfully applied to engineer recom-
binant single-stranded positive-sense viruses include: cloning the
heterologous sequence in frame with a viral protein (Bonaldo et al.,
2002, 2005; Burke et al., 1988; Evans et al., 1989), cloning an internal
Fig. 6. RT-PCR diagnostics and sequence analysis of vR6-LC-PmeIDsRed and revertants. (A) Schematic of the ORF2 organization and the diagnostic PCR primers with the expected
ampliﬁed fragment lengths for vR6 and vR6-LC-PmeIDsRed. The grey box corresponds to the DsRed insertion. E/A corresponds to the amino acid cleavage site. (B) RT-PCR analysis of
a ﬂuorescent plaque (lane 2), six non-ﬂuorescent plaques (lanes 3–6), and vR6 (lane 9) virus with primers ﬂanking the site of insertion. M, Invitrogen's 100 bp DNAmolecular weight
marker (lanes 1 and 11). Products were analyzed in a 1.5% agarose gel. Sizes are indicated in nucleotides. (C) Schematic representation of the sequence analysis corresponding to the
six non-ﬂuorescent plaques. Dotted lines correspond to deleted portions of the insertion. Numbers identify the positions with regard to the parental plasmid (pR6-LC-PmeIDsRed).
25E.J. Abente et al. / Virology 400 (2010) 18–31ribosomal entry site (IRES) adjacent to the heterologous sequence to
create a dicistronic expression vector (Alexander et al., 1994;
Hefferon et al., 1997; Lu et al., 1995; Pierson et al., 2005), and
cloning a heterologous sequence that contains an artiﬁcial viral
cleavage site adjacent to a viral ORF (Andino et al., 1994; Bonaldo et
al., 2007; Fan et al., 2008; Henke et al., 2001; Hoﬂing et al., 2000;
Mattion et al., 1994; Thomas et al., 2003). We decided to employ the
Tn7 transposon mutagenesis system to identify sites in FCV that can
tolerate an insertion because it has been successfully applied to other
single-stranded, positive sense RNA viruses (Atasheva et al., 2007;
Moradpour et al., 2004). For the hepatitis C virus, the mutagenesissystem allowed researchers to develop a recombinant replicon
system that expresses GFP fused to a nonstructural protein
(Moradpour et al., 2004), which has been useful for analysis of HCV
replication complexes (Wolk et al., 2008). Similar experiments were
performed using Sindbis virus, in which a nonstructural protein was
identiﬁed that could tolerate the insertion of a ﬂuorescent protein
(Atasheva et al., 2007), and analogous studies of replication
complexes were conducted (Gorchakov et al., 2008).
Random transposon mutagenesis was applied to a region of FCV
that encompassed ORF2 and the ﬁrst 12 nucleotides of ORF3 to
determine whether the virus could tolerate a 15-nt insertion. Despite
26 E.J. Abente et al. / Virology 400 (2010) 18–31a low coverage of the region of interest (∼1x) by transposon
mutagenesis, the initial analysis of a library of randomly mutagenized
clones yielded two sites that could tolerate a 15-nt insertion. The two
sites of insertion were located in different viral proteins: VP2 and the
LC. It was unexpected that the VP2 could tolerate an insertion because
it has been shown that the N-terminus of VP2 contains domains that
are essential for viral replication (Sosnovtsev et al., 2005). Despite
initially tolerating a heterologous sequence fused to VP2 (an HA
epitope), the insertion of the recombinant virus was rapidly modiﬁed
by partial deletion of the foreign insertion.
Two heterologous sequences were cloned into the site identiﬁed in
the LC protein (AcGFP, DsRed), and recombinant viruses were
recovered. Further study of these viruses showed that they produced
the LC protein as an intact GFP or DsRed fusion protein. The published
data concerning the vesivirus LC protein is limited, and little is known
about its structure and function. The precursor cleavage event that
releases the LC from the mature VP1 occurs shortly after the capsid
precursor is translated (Carter, 1989; Carter et al., 1992; Sosnovtsev
et al., 1998) and is essential for a productive virus infection. Recent
data suggests that the LC enhances the replication of the Norwalk
norovirus RNA replicon (Chang et al., 2008), in association with an
increase in low density lipoprotein receptor mRNA levels (Chang,
2009); however, the mechanism of enhancement is not clear. It has
been proposed that the LC may function as a non-structural protein
because it was not detected in puriﬁed FCV virions (Tohya et al.,
1999). However, LC protein was not detected in isolated fractions
containing active replication complexes (Green et al., 2002b). Until
the function of the LC is elucidated, it will not be known whether a
functional homolog is present in other caliciviruses. Further study of
LC recombinant viruses may lead to new insight into the role of this
protein in vesivirus replication.
An unexpected observation from the study was that the ﬂuores-
cently tagged LC protein was not clearly visualized by microscopy
until 7.5 h.p.i. (Fig. 5). The LC protein is encoded as part of the capsid
precursor protein in ORF2 of the subgenomic RNA, and abundantly
produced and detected as early as 2 h.p.i. in Western blots (Fig. 3C).
The lag in detection of ﬂuorescence from the LC fusion proteins in the
recombinant viruses may be due to the time required for the folding
and maturation of the chromophore following expression of the
ﬂuorescent protein. It is possible also that fusion of the ﬂuorescent
protein to the LC may affect the dynamics of the chromophore
maturation, which could then lead to a lower signal readout. We are
currently investigating the use of ﬂuorescent proteins that are more
photostable and produce brighter signals in an effort to enhance the
observation of protein trafﬁcking early in the virus life cycle.
RNA viruses can rapidly adapt to selective pressures due to
recombination events, in addition to the well-characterized poor
ﬁdelity of RNA-dependent RNA polymerases (Duffy et al., 2008; Lin
et al., 2009). Serial passage of the constructs presented in this paper
resulted eventually in the reduction or loss of foreign protein
expression, as the virus reverted back to wt or deleted sequences in
the original insertion. Sequencing of these LC-modiﬁed viruses in
individual plaques revealed that fragments of the foreign sequence
often remained fused to the LC (Fig. 6), consistent with data
reported for recombinant poliovirus revertants (Mueller and
Wimmer, 1998). The proposed mechanism by which recombinant
polioviruses revert to wild-type is via nonhomologous RNA
recombination during minus strand synthesis (Mueller and Wim-
mer, 1998). It is possible that caliciviruses use the same mechanism
for reversion, but further studies will be needed. Such studies may
lead also to the design of recombinant viruses with greater stability.
The length, primary nucleotide and amino acid sequences, and
context of the insertion in the genome are likely important factors in
stability. For example, variation was observed in the length of the
insertions that were tolerated between LC and VP2 in the virus, with
VP2 limited to small epitopes. And although a small HA epitope (9amino acids) in VP2 was tolerated, albeit poorly, a six amino acid
insertion that contained a tetra cysteine motif was lethal (unpub-
lished data). Host cell factors may inﬂuence also the stability of
recombinant viruses. The stability of a recombinant GFP-expressing
hypovirus RNA genome was enhanced in its fungal host cell
(Cryphonectria parasitica) when the host cell dicer gene dcl-2 was
disrupted (Zhang and Nuss, 2008). It will be interesting to
investigate what, if any, cellular factors affect the stability of foreign
sequences for FCV.
There are several reports that caliciviruses undergo recombination
in nature and emerging recombinants have been associated with at
least two reported norovirus outbreaks (Fukuda et al., 2008; Vidal
et al., 2006). The site of recombination has been predominantly
located at, or near the ORF1/2 junction, within the polymerase or
capsid sequence(Bull et al., 2007; Chhabra et al., 2009; Coyne et al.,
2006; Forrester et al., 2008; Fukuda et al., 2008; Guo et al., 2009; Jiang
et al., 1999; Jin et al., 2008; Nayak et al., 2008, 2009; Phan et al., 2007a,
2007b; Rohayem et al., 2005; Waters et al., 2007). It has been shown
that upon calicivirus infection, membrane rearrangement occurs
(Green et al., 2002b; Love and Sabine, 1975; Studdert and O'Shea,
1975), which is thought to allow the formation of replication
complexes. Enzymatically-active replication complexes can be isolat-
ed from FCV-infected cells (Green et al., 2002b), but it is not known
how the dynamics of replication complex formation are affected
during a co-infection. It is possible that mixed replication complexes
are formed during a co-infection, sequestering genomic RNA from
different viruses inside the same replication complex, allowing
recombination to occur. Work is in progress to generate additional
recombinant FCV variants with markers in other regions of the
genome, in particular the nonstructural proteins encoded in ORF1.
These viruses may further allow the characterization of replication
sites during a co-infection, and lead to new insight into the
mechanisms of recombination.
The ﬂuorescently tagged viruses should provide also a supple-
mentary tool for analysis of virus-host cellular interactions. In
addition to conﬁrming interactions of viral proteins with host cellular
proteins biochemically, the recruitment of host cellular proteins to the
site of viral translation can now be monitored in real-time. The
availability of several host cellular proteins tagged with ﬂuorescent
protein should allow an in-depth analysis of the dynamics of the host
cellular membrane rearrangement and the recruitment of host
cellular proteins essential for virus replication.
Conclusions
Transposon-mediated mutagenesis was successfully applied to
FCV, and recombinant FCV variants were engineered that expressed a
ﬂuorescent protein fused to the LC. Viral protein processing and RNA
replication of the recombinant FCV variants were analyzed and did
not differ signiﬁcantly from the wild-type strain. The stability of the
heterologous insertion was monitored by PCR and deleterious (non-
ﬂuorescent) viruses were sequenced, providing a new approach for
the analysis of RNA repair and recombination. The ability to generate
infectious FCV variants expressing foreign protein and RNA sequences
has broad applications for basic research in calicivirus replication.
Furthermore, this approach may lead also to practical applications
such as gene delivery and improved vaccines for FCV and other
members of the Caliciviridae.
Materials and Methods
Viruses and Cells
Feline calicivirus strain vR6, derived from the infectious cDNA
clone of the Urbana strain designated pR6, was described previously
(Sosnovtsev et al., 2005), and will be referred to as wild-type (wt).
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modiﬁed Eagle's medium (designated as maintenance medium, Lonza
Inc., Allendale, NJ) containing amphotericin B (0.25 μg/ml, Mediatec,
Inc, Manassas, VA), penicillin (250 U/ml, Mediatec), streptomycin
(250 μg/ml, Mediatec) and L-Glutamine (2 mM, Mediatec) supple-
mented with 10% heat-inactivated fetal bovine serum (Invitrogen
Corporation, Carlsbad, CA).
Construction of Intermediate Plasmid
A plasmid designated Topo-VP1/VP2 was generated by cloning
DNA fragments derived by PCR from pR6 as template into Invitrogen's
Topo TA vector. The primer pair: sense primer, 5′-GGCATGACCGCCC-
TACACTGT (designated URB5273F) and antisense primer, 5′-
GCGTTGTTGTCCAAGCGCAGCC (designated URB7391R) ampliﬁed the
entire ORF2 and the ﬁrst 96 nt of ORF3. The ampliﬁed and cloned FCV
sequences included the unique restriction sites BstBI and AvrII, which
were used for directional cloning back into the pR6 backbone
following transposon mutagenesis.
Construction of cDNA Library of FCV Clones Containing a Randomly
Inserted 15-bp Sequence
The protocol was designed based on procedures previously
published (Moradpour et al., 2004; Teterina et al., 2009). To focus
the mutagenesis on a speciﬁc region of the FCV genome, the
transposon-mediated mutagenesis was performed on the intermedi-
ate plasmid, Topo-VP1/VP2.
A cDNA library of Topo subclones with random transprimer
insertions was created by using the GPS-LS linker scanning system
according to the manufacturer's instructions (New England Biolabs,
Beverly, MA). The GPS-LS insertion mutagenesis is performed in three
major steps: ﬁrst, a 1383 bp transprimer sequence, that is ﬂanked by
PmeI restriction sites and encodes the chloramphenicol resistance
gene, is randomly inserted into a DNA target; second, all but 10 bp of
the transprimer is removed by PmeI digestion; and ﬁnally, the ligation
of themutagenized DNA target results in a 15 bp insertion (10 bp from
the transprimer which includes the PmeI site, and a 5 bp duplication
of target DNA created by the transposition reaction).
Brieﬂy, upon producing the GPS reactionmixture of an unampliﬁed
library of transprimer insertions, 5 μl of the reactionwere transformed
into competent cells. Competent cells were grown for 1 hour at 37 °C
with 600 μl of S.O.C.media (Invitrogen). Twohundred μl of the cellmix
were added to 3 plates containing both chloramphenicol and
kanamycin to select for transformants, and incubated overnight at
37 °C. Theﬁrst library of randommutations consistedof approximately
2,763 colonies. Ten ml of LB broth were added to the plates and the
colonies were scraped and collected. Plasmid DNA was puriﬁed from
the resuspended colonies using a DNAMini-Prep kit (Qiagen, Valencia,
CA). The three samples of DNA plasmid were then proportionally
combined into a pool that contained approximately 3 μg of DNA. One
μg of pooled DNA was digested using the restriction enzyme that
ﬂanked the region of interest (BstBI and AvrII), and separated on a 1%
agarose gel. The scanned region of interest (the 2027 bp sequence of
FCV bordered by the restriction sites BstBI and AvrII) plus the
transprimer insertionwas identiﬁed based on its size, and gel puriﬁed.
The region of interest plus the transprimer insertion was ligated back
into the parental full-length cDNA backbone of the pR6 plasmid, and
transformed into competent cells. Identical to the previous pooling
step, competent cells were grown for 1 hour at 37°C with 600 μl of S.O.
C. media (Invitrogen). Two hundred μl of the cell mix were added to 3
plates containing both chloramphenicol and carbenicillin to select for
transformants, and incubated overnight at 37°C. The second library of
random insertion consisted of approximately 1,093 colonies. Tenml of
LB broth were added to the plates and the colonies were scraped and
collected. Plasmid DNAwas puriﬁed from the resuspended colonies asdescribed above and three samples of DNA plasmid were then
proportionally combined into a pool that contained approximately
3 μg of DNA. One μg of the pool was digested using the restriction
enzyme PmeI. The digestion reaction was separated on a 1% agarose
gel, and the parental backbone, minus the transprimer, was excised
and gel puriﬁed. The pool of mutagenized parental backbone was
religated, and transformed into competent cells. Identical to the
previous pooling steps, competent cells were grown for 1 hour at 37°C
with 600 μl of S.O.C. media (Invitrogen). The cell mix (200 μl) was
added to 3 plates containing carbenicillin to select for transformants,
and incubated overnight at 37 °C. The ﬁnal library of random
mutations consisted of approximately 2,348 colonies. Ten ml of LB
broth were added to the plates and the colonies were scraped and
collected. Plasmid DNAwas puriﬁed from the resuspended colonies as
above, and the three samples of DNAplasmidwere thenproportionally
combined into a pool that contained approximately 5 μg of DNA. Two
μg of the ﬁnal pool of mutagenized full-length FCV, containing 15-nt
insertions randomly distributed in ORF2 and the ﬁrst 12 nucleotides of
ORF3 (the region of FCV bordered by the restriction sites BstBI and
AvrII) were used to test for recovery of virus.
Recovery of Virus
Virus was recovered from plasmid DNA by using the MVA/T7
expression system, described previously (Sosnovtsev et al., 2002).
Brieﬂy, conﬂuent CRFK cell monolayers in 6-well plates (approxi-
mately 2×106 cells) were infected with MVA/T7 (a gift of Dr.
Bernard Moss) at an MOI of 10 and incubated for 1 h at 37 °C. The
supernatant was removed, and 2 ml of maintenance media were
added to the cells. Transfections were carried out using
Lipofectamine 2000 (Invitrogen) according to the manufacturer's
instructions. Following incubation for 24-48 hours at 37°C, medium
from the transfected cell monolayer was transferred to a fresh cell
monolayer, which was monitored for the development of viral CPE.
If CPE was observed, the supernatant was used to perform a plaque
assay, and individual plaques were analyzed.
To conﬁrm that recovered virus originated from the engineered
constructs, reverse-transcriptase (RT)-PCR products derived from
viral RNAwere analyzed by direct sequencing. RNAwas puriﬁed using
the RNeasy mini kit (Qiagen). As a control for the presence of DNA
from the original plasmid used to synthesize the RNA for transfection,
PCR was performed on the isolated viral RNA in the absence of RT.
Construction of Recombinant FCV Infectious Clones
To reconstruct the recovered transposon-modiﬁed virus, the RNA
extracted from the plaque of a mutagenized virus that contained a 15-
nt insertion in the LC (encoding a PmeI restriction site; Table 1) was
used for RT-PCR ampliﬁcation using the following primer pair that is
complementary to the FCV genome: sense primer 5′- GAGTTG-
CATCTTGAGCCGCC (UrbanaFL5174F) and antisense primer 5′-
GCGTTGTTGTCCAAGCGCAGCC (UrbanaFL7391R). This DNA fragment
was treated with BstBI and AvrII and subsequently cloned back into
the infectious cDNA clone pR6 using the same restriction sites to
reconstruct the mutagenized LC viral sequence. The reconstructed
plasmid containing the 15-nt insertion in the LC protein was
designated pR6-LC-15.
The multiple cloning site was then inserted into the pR6 clone
using a QuikChange XL Site-Directed Mutagenesis kit (Stratagene's,
La Jolla, CA) and PCR mutagenesis. The sequences of oligonucleotides
used to mutagenize the cDNA clone are available upon request.The
infectious clone with the multiple cloning site was designated pR6-
LC (Fig. 1A).
The DsRed and GFPmonomeric proteins were PCR-ampliﬁed using
the pDsRed-Monomer-N1 and pAcGFP1-Monomer-N1 vectors as
templates (Clontech), respectively, to include bordering KpnI and
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ampliﬁed DsRed or GFP fragments were digested, puriﬁed, and ligated
into the KpnI and AﬂII sites of the pR6-LC clone using a Rapid Ligation
kit (Roche). The resulting plasmids were designated pR6-LC-GFP and
pR6-LC-DsRed (Fig. 1B).
Plaque Assay
Viruses were titered on CRFK cells. CRFK cells were seeded onto 6-
well plates, and upon conﬂuency, the monolayers were infected with
serial dilutions of virus prepared in Dulbecco's modiﬁed Eagle's
medium. Plates were incubated for 60 min (37°C, 5% CO2), with gentle
agitation every 15 min. The inocula were removed, and monolayers
were overlaidwith 2mlmaintenancemedia containing 1% agarose gel
(Invitrogen). Plates were then incubated for approximately 48 hr at
37 °C, in humidiﬁed 5% CO2. Cells were ﬁxed with 10% formaldehyde
and the agarose overlay was removed. The ﬁxed cells were stained
with 1% (w/v) crystal violet solution, washed, and viral plaques were
counted.
Western Blot Analysis
Conﬂuentmonolayers of CRFK cells in 150 cm2 ﬂasks were infected
with vR6, vR6-LC-GFP, and vR6-LC-DsRed respectively, and following
complete lysis (approximately 48 hours), the ﬂasks were submitted to
three freeze-thaw cycles. The insoluble material was pelleted by
centrifugation at 2,655×g for 10 min and the pellet was resuspended
in 500 μl PBS. A 10 μl aliquot was mixed with an equal volume of 2X
Tris-glycine SDS sample buffer (Invitrogen) containing 5% β-mercap-
toethanol. The sample was subjected to SDS-PAGE and Western blot
analysis as described below.
For VP1 detection over time, CRFK cells were infected at an MOI of
1 with vR6, vR6-LC-GFP, and vR6-LC-DsRed. At the desired time point,
approximately 300 μl of Tris-glycine SDS sample buffer was added
directly to the monolayer to disrupt the cells, and the lysate was
stored at -70 °C until further use.
Samples were heated at 95 °C for 5 min in 1X Tris-glycine SDS
sample buffer containing 5% β-mercaptoethanol. Western blot
analysis was performed using 4-20% Tris-glycine SDS-PAGE gels
(Lonza). Proteins were transferred by dry blotting to nitrocellulose
membranes using Invitrogen's iBlot apparatus, andmembranes were
incubated with guinea pig anti-FCV virion hyperimmune serum,
rabbit anti-LC hyperimmune serum (Sosnovtsev and Green, 2000),
rabbit polyclonal anti-DsRed (Clontech), or mouse monoclonal anti-
GFP (Clontech). The binding of the primary antibodies was detected
with goat anti-guinea pig (Kirkegaard & Perry Laboratories, Gaithers-
burg, MD), anti-rabbit or anti-mouse secondary antibodies (Thermo
Scientiﬁc, Waltham, MA) conjugated with horseradish-peroxidase,
followed by development with the SuperSignal Chemiluminescent
Substrate (Thermo Scientiﬁc).
Western blots were stripped using the Restore Plus Western Blot
Stripping Buffer (Thermo Scientiﬁc), and incubated with monoclonal
HRP-conjugated anti-β-actin antibody. SeeBlue Plus2 Pre-Stained
Standard (Invitrogen) was used to estimate molecular weights of the
proteins detected by Western blot.
Subgenomic Expression Plasmids
To construct vectors expressing the FCV capsid precursor protein for
trans-cleavage analysis, the entire FCV subgenomic RNA region present in
pR6, pR6-LC-GFP, or pR6-LC-DsRed was cloned into the pCI expression
vector (Promega, Madison, WI). The following primer pair was used to
amplify the subgenomic region of each construct (including ORF2, ORF3,
the 3′-NTR, poly-A tail, and a unique NotI restriction site downstream of
thepoly-A tail), and to introduce a SalI restriction site (boldface)upstream
of the subgenomic transcription initiation site: sense primer 5′-CGCCCTACACTGTGAGTCGACTGTGTTCGAAGTTTG (pR6-SubGen-SalI F)
and antisense primer that is downstream of the NotI restriction site 5′-
CCCAGTCACGACGTTGTAAAAC (pR6-Dnstream PolyA R). The DNA frag-
ments were treated with SalI and NotI, and cloned into pCI vectors
(Promega) using the same restriction sites. The plasmidswere designated
pCI-vR6, pCI-vR6-LC-GFP, and pCI-vR6-DsRed (Fig. 1C). All plasmidswere
conﬁrmed by sequence analysis.
Coupled In Vitro Transcription and Translation Reaction and
Immunoprecipitation Assay
One to 5 μg of plasmid DNA were used as template in a coupled
transcription and translation reaction (TNT T7 Coupled Reticulocyte
Lysate System; Promega). For radiolabeling of synthesized protein,
[35S] methionine (N1,000 Ci/mmol) from Amersham/GE Healthcare
(Waukesha, WI) was added at a concentration of 1.5 mCi/ml.
Immunoprecipitation of the LC protein from the TNT reaction was
performed as described previously (Sosnovtsev et al., 1998). Brieﬂy,
20 μl of the TNT reaction were incubated with 40 μl of either mock-
infected lysate or vR6 infected lysate at 37 °C for 3 hr. The resulting
mixture was diluted with 60 μl of radioimmunoprecipitation assay
(RIPA) buffer. The mixtures were incubated with rabbit post-
immunization serum (5 μl) raised against the FCV LC protein
expressed in E. coli, and the immune complexes were precipitated
with protein A beads (Sigma Chemical Co., Saint Louis, MO). The
binding and washing conditions were performed as described
previously (Sosnovtsev et al., 1998). Following separation of
the proteins in a 4-12% Tris-glycine SDS-PAGE gel, the gel was
dried and exposed to Biomax MR ﬁlm (Kodak, Rochester, NY) for
autoradiography.
Multiple-cycle Growth Kinetics
CRFK monolayers were infected with vR6, vR6-LC-GFP, or vR6-LC-
DsRed at a multiplicity of infection (MOI) of 0.01 and incubated at
37°C in 5% CO2. Cell lysates were collected at various times post-
infection (p.i.) and frozen at -70 °C. Following three freeze-thaw
cycles, the titer at each time-point was determined by plaque assay in
CRFK cells as described above. Results depicted in Fig. 2B represent the
mean value of each time point duplicate determined in two
independent plaque titration assays, and the error bars represent
one standard deviation. The graph was prepared using the software
Prism from GraphPad (La Jolla, CA).
Extraction of Viral RNA
CRFK monolayers (2×106 cells) were mock infected or infected
with vR6, vR6-LC-DsRed or vR6-LC-GFP at a multiplicity of infection
of 1 and incubated at 37 °C in 5% CO2. At 8 h p.i. 300 μl of Trizol
(Invitrogen) reagent was added directly to the monolayer, and RNA
was extracted following the instructions of the manufacturer. The
viral RNA of individual plaques was puriﬁed using the RNeasy
mini kit (Qiagen).
Preparation of RNA Transcripts and Biotinylated RNA Probes
An RNA probe was designed as described in Green et al. (Green
et al., 2002b). Brieﬂy, using pR6 as a template, a forward primer that
contained a T7 RNA polymerase promoter sequence and a reverse
primer were used to generate a DNA fragment that was comple-
mentary to nt 5686 to 5987 of the ORF2. DNA fragments were
agarose gel puriﬁed and extracted from the agarose (Qiagen).
Approximately 1 μg of the DNA fragment was used as the template
for in vitro transcription with the Ribomax Express T7 transcription
kit (Promega). Transcribed RNA was puriﬁed with the RNeasy mini
kit (Qiagen).
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reagents in the BrightStar psoralen-biotin nonisotopic labeling kit
(Ambion, Carlsbad, CA). Brieﬂy, 0.5 μg of RNA was cross-linked to the
psoralen-biotin reagent on ice with a 365-nm UV light for 45 min.
Unincorporated label was removed by 1-butanol extraction. The
biotinylated RNA probes were stored at -70 °C.
Northern Blotting
Northern blot analysis for the detection of FCV RNAwas performed
with the NorthernMax-Gly system (Ambion) as described by Green et
al. (Green et al., 2002b), with slight modiﬁcations. Brieﬂy, the viral
RNA was denatured with glyoxal loading dye for 30 min at 50 °C, and
separated in a 1% LE-agarose gel. The RNA was transferred to a Bright-
Star-Plus membrane by capillary blotting. The membrane was treated
with UV light to cross-link the RNA to the membrane, and was then
incubated with Ultrahyb buffer at 68 °C for 30 min. The membrane
was then incubated overnight at 68°C with the sense biotinylated RNA
transcript probe. Detection of bound biotinylated RNA probe was
conducted following the instructions of the Bright Star BioDetect kit
(Ambion).
Nucleotide Sequence Analysis
All plasmids were sequenced to conﬁrm the presence of the
desired engineered insertions. Nucleotide sequencing analysis was
performed on an ABI 3730 automated sequencer (Applied Biosystems,
Carlsbad, CA) with the Big Dye Terminator reagents, version 3.1.
Recovery of transposon mutagenized virus was conﬁrmed by
direct sequence analysis of RT-PCR products derived from viral RNA as
described previously (Sosnovtsev et al., 1998). The sequences of
oligonucleotides used to amplify and sequence virus-speciﬁc cDNA
fragments are available upon request.
The following primer pair, that ﬂanks the site of insertion into the
LC coding sequence, was used in a “diagnostic” PCR to examine the
stability of the insert: sense primer 5′- CTTGAGTCTATCCTGGGCGATG
(UrbFL5500F), and the antisense primer 5′- ATCAGCAGCGGTTGA-
CATTTG (UrbFL5758R).
Microscopy Analysis
Plaques were visualized using a Leica DMI4000 B microscope, and
images were captured using a QImaging Retiga-2000R camera
(Surrey, BC Canada). Images were processed using iVision 4.0.14
software (BioVision, Exton, PA).
For live-cell imaging of single infection, cells were infected with
vR6-LC-PmeIDsRed at an MOI of 10. For the co-infection experi-
ment, cells were infected with both vR6-LC-GFP and vR6-LC-DsRed
at a multiplicity of infection (MOI) of 2 and 1, respectively. The
infected cells were then transferred to a temperature-controlled
chamber (37 °C/ 5% CO2). Time-lapse confocal imaging was
obtained using a Leica SP2-AOBS Confocal Microscope. Time-course
images were processed using Imaris software (Bitplane, Zurich,
Switzerland).
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